Meeting Overview | We are pleased to invite you to our St Gallen Satellite Symposium titled, “Perplexing Questions in Early Breast Cancer: Answers from the Experts," to be held on 17 March 2011 in St Gallen, Switzerland.
During this interactive meeting, leaders in the field will discuss clinical issues in the field of early breast cancer. |
Date and Location | Olma Messen
Main Auditorium Hall 9.1
Sankt Jakobstrasse 94
9000 St Gallen, Switzerland
|
Target Audience | This educational activity is designed for medical oncologists, radiation oncologists, surgical
oncologists, pathologists, and other healthcare providers involved and/or interested in the
management of patients with breast cancer |
Learning Objectives | Upon completion of this educational activity, participants should be able to:
- Summarize the clinical challenges in the management of patients with breast cancer
- Review recent clinical advances in the treatment of breast cancer including novel combination regimens
- Discuss specific clinical settings and the factors which that may contribute to improved patient outcomes
- Identify therapeutic strategies to optimize outcomes for patients with breast cancer
- Distinguish the distinctions and potential appropriate applications of therapeutic interventions for patients with breast cancer
|
 Faculty | Chair and Moderator:
Martine Piccart-Gebhart, MD, PhD
Institute Jules Bordet
Brussels, Belgium
Faculty:
Angelo Di Leo, MD, PhD
Hospital of Prato
Istituto Toscano Tumori
Prato, Italy |
|
Michael Gnant, MD
Medical University of Vienna
Vienna, Austria
|
Clifford Hudis, MD
Memorial Sloan-Kettering Cancer Center
New York, New York, United States |
|
Christian Jackisch, MD, PhD
Klinikum Offenbach
Offenbach, Germany |
|
Agenda |
| 18.00 |
|
Introduction and welcome
Martine Piccart-Gebhart, MD, PhD |
| 18.05 |
|
Bone-targeted therapy for early breast cancer: Where do we stand now?
Michael Gnant, MD |
| 18.15 |
|
Panel opinion and take-home message |
| 18.25 |
|
Gene expression profiling for breast cancer: Why and for whom?
Christian Jackisch, MD, PhD |
| 18.35 |
|
Panel opinion and take-home message |
| 18.45 |
|
What have we learned from neoadjuvant strategies for HER2-amplified breast cancer and how should we apply it?
Angelo Di Leo, MD, PhD |
| 18.55 |
|
Panel opinion and take-home message |
| 19.05 |
|
How can we efficiently move promising treatment strategies from the metastatic to the adjuvant setting?
Clifford Hudis, MD |
| 19.15 |
|
Panel opinion and take-home message |
| 19.25 |
|
Conclusion
Martine Piccart-Gebhart, MD, PhD |
|
|
|
|
Organizer | This meeting is a prIME Oncology activity.
|
Support | Financial support for this activity has been provided by Amgen Europe GmbH, Eisai Europe Limited, F. Hoffmann-La Roche Ltd, Genomic Health, Inc and GlaxoSmithKline Oncology.
|
|
